醫學生物學研究領域 2019

Hsiao, Michael

  • Chiou J, Chang YC, Tsai HF, Lin YF, Huang MS, Yang CJ, Hsiao M*, 2019, “FSTL1 interacts with SPP1 to promote lung cancer metastasis”, Cancer Research, In Press. (SCI)
  • Chiou J, Chang YC, Jan YH, Tsai HF, Yang CJ, Huang MS, Yu YL, Hsiao M*, 2019, “Overexpression of BZW1 is an independent poor prognosis marker and its down-regulation suppresses lung adenocarcinoma metastasis”, Scientific Reports, 9(1):14624. (SCI)
  • Huang WT, Chan MH, CHen X, Hsiao M*, Liu RS, 2019, “Theranostic nanobubble encapsulating a plasmon-enhanced upconversion hybrid nanosystem for cancer therapy”, Theranostics, In Press. (SCI)
  • Wen YT, Wu ATH, Bamodu OA, Wei L, Lin CM, Yen Y, Chao TY, Mukhopadhyay D, Hsiao M*, Huang HS, 2019, “A Novel Multi-Target Small Molecule, LCC-09, Inhibits Stemness and Therapy-Resistant Phenotypes of Glioblastoma Cells by Increasing miR-34a and Deregulating the DRD4/Akt/mTOR Signaling Axis”, Cancers, Sep. 26;11(10) 1442. (SCI)
  • CH Lin, HY Li, YP Liu, PF Kuo, WC Wang, FC Lin, WL Chang, BS Sheu, YC Wang, WC Hung, HC Cheng, YC Yao, MJ Calkins., M Hsiao, PJ Lu, 2019, “High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma”, Therapeutic Advances in Medical Oncology, 11 175883591987532. (SCI)
  • Tai PA, Liu YL, Wen YT, Lin CM, Huynh TT, Hsiao M, Wu ATH, Wei L, 2019, “The development and applications of a dual optical imaging system for studying glioma stem cells”, Molecular Imaging, 18:1536012119870899. (SCI)
  • Chang YC, Chiou J, Yang YF, Su CY, Lin YF, Yang CN, Lu PJ, Huang MS, Yang CJ, Hsiao M*, 2019, “Therapeutic Targeting of Aldolase A Interactions Inhibits Lung Cancer Metastasis and Prolongs Survival.”, Cancer Research, Sep. 15;79(18):4754-4766. (SCI, SSCI) (IF: 9.13; SSCI ranking: 9.5%)
  • Jan YH, Lai TC, Yang CJ, Huang MS, Hsiao M*, 2019, “A co-expressed gene status of adenylate kinase 1/4 reveals prognostic gene signature associated with prognosis and sensitivity to EGFR targeted therapy in lung adenocarcinoma”, Scientific Reports, Aug 23;9(1):12329. (SCI)
  • Chang YC, Tsai HF, Huang SP, Chen CL, Hsiao M*, Tsai WC, 2019, “Enrichment of Aldolase C Correlates with Low Non-Mutated IDH1 Expression and Predicts a Favorable Prognosis in Glioblastomas”, Cancers, Aug 23;11(9). pii: E1238. (SCI)
  • Chan MH, Liu RS, Hsiao M*, 2019, “Graphitic carbon nitride-based nanocomposites and their biological applications: a review.”, Nanoscale, Aug. 15, 11, 14993–15003. (SCI)
  • Tien CP, Chen CH, Lin WY, Liu CS, Liu KJ, Hsiao M, Chang YC, Hung SC, 2019, “Ambient particulate matter attenuates Sirtuin1 and augments SREBP1-PIR axis to induce human pulmonary fibroblast inflammation: molecular mechanism of microenvironment associated with COPD.”, Aging (Albany, NY), Jul 12;11.
  • Huang YJ, Jan YH, Chang YC, Tsai HF, Wu ATH, Chen CL, Hsiao M*, 2019, “ATP synthase subunit epsilon (ATP5E) is a marker of poor clinical outcomes that promotes EMT of colorectal cancer by modulating AMPK-AKT-HIF-1α signaling axis”, Journal of Clinical Medicine, 8, 1070. (SCI)
  • Hung WY, Chang JH, Cheng Y, Cheng GZ, Huang HC, Hsiao M, Chung CL, Lee WJ, Chien MH, 2019, “Autophagosome accumulation induced by the antipsychotic drug penfluridol triggers non-apoptotic cell death of lung cancer via unfolded protein response signaling”, Cell Death Disease, Jul 15;10(8):538. (SCI)
  • Chang CY, Chang SL, Leu JD, Chang YC, Hsiao M, Lin LT, Lin HN, Lee YJ, 2019, “Comparison of cofilin1 and Twist1 protein expression in human nonsmall cell lung cancer tissues.”, Oncology Reports, 42:805-816. (SCI) (IF: 2.976; SSCI ranking: 59.5%)
  • Chan MH, Lai CY, Chan YC, Hsiao M*, Chung RJ, Chen X, Liu RS, 2019, “Development of upconversion nanoparticle-conjugated indium phosphide quantum dot for matrix metalloproteinase-2 cancer transformation sensing.”, Nanomedicine (London, England), Jul;14(14):1791-1804. (SCI)
  • Chang WM, Chang YC, Yang YC, Lin SK, Chang MH, Hsiao M*, 2019, “AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway”, Journal of Experimental & Clinical Research, June 10;38:245. (SCI)
  • Yang SC, Liu JJ, Wang CK, Lin YT, Tsai SY, Chen WJ, Huang WK, Tu PA, Lin YC, Chang CF, Cheng CL, Lin H, Lai CY, Lin CY, Lee YH, Chiu YC, Hsu CC, Hsu SC, Hsiao M, Schuyler SC, Lu FL, Lu J, 2019, “Down-regulation of ATF1 leads to early neuroectoderm differentiation of human embryonic stem cells by increasing the expression level of SOX2.”, FASEB Journal, June 26:fj201800220RR. (SSCI) (IF: 5.595; SSCI ranking: 13.1%)
  • Chien MH, Lin YW, Wen YC, Yang YC, Hsiao M, Chang JL, Huang HC, Lee WJ, 2019, “Targeting the SPOCK1-snail/slug axismediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis”, Journal of Experimental & Clinical Cancer Research, June 10;38:246. (SCI)
  • Lin TC, Yeh YM, Fan WL, Chang YC, Lin WM, Yang TY, Hsiao M*, 2019, “Ghrelin upregulates oncogenic Aurora A to promote renal cell carcinoma invasion”, Cancers, March 4;11, 303. (SCI)
  • Yeh CN, Chen MH, Chang YC, Wu RC, Tsao LC, Wang SY, Cheng CT, Chiang KC, Chen TW, Hsiao M, Weng WH, 2019, “Over-expression of TNNI3K is associated with early-stage carcinogenesis of cholangiocarcinom”, Molecular Carcinogenesis, 58(2), 270-278. (SCI)
  • Chuang PK, Hsiao M, Hsu TL, Chang CF, Wu CY, Chen BR, Huang HW, Liao KS, Chen CC, Chen CL, Yang SM, Kuo CW, Chen P, Chiu PT, Chen IJ, Lai JS, Yu CT, Wong CH*, 2019, “Signaling pathway of globo-series glycosphingolipids and β1,3-galactosyltransferase V (β3GalT5) in breast cancer”, Proceedings of the National Academy of Sciences U.S.A., Feb 26, 116(9), 3518-3523. (SCI)
  • Jan YH, Lai TC, Yang CJ, Lin YF, Huang MS, Hsiao M*, 2019, “Adenylate kinase-4 modulates oxidative stress and stabilizes HIF-1α to drive lung adenocarcinoma metastasis”, Journal of Hematology and Oncology, Jan 29;12(1):12. (SCI)
  • Kuo WY, Hsu HJ, Wu CY, Chen HS, Chou YC, Tsou YL, Peng HP, Jian JW, Yu CM, Chiu YK, Chen IC, Tung CP, Hsiao M, Lin CL, Wang YA, Wang AH, Yang AS, 2019, “Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models.”, mAbs, Jan;11(1):153-165. (SCI)
  • Chuang HH , Wang PH , Niu SW, Zhen YY, Huang MS, Hsiao M, Yang CJ, 2019, “Inhibition of FAK signaling elicits Lamin A/C-associated nuclear deformity and cellular senescence”, Frontiers in Oncology, 9:22. (SCI)
  • Su YK, Bamodu OA, Tzeng YM, Hsiao M, Lin CM, Yeh CT, 2019, “Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of the glioblastoma cells, as well as potentiate the anticancer effect of temozolomide”, Phytomedicine, Jan 19;61:152840. (SCI)

Hsieh, Shie-Liang

  • Sung PS, Huang TF, Hsieh SL*, 2019, “Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A/TLR2”, NATURE COMMUNICATIONS, 10(1):2402. (SCI)

Hwang-Verslues, Wendy W.

  • Fararjeh, A., Tu, S.H., Chen, L.C., Cheng, T.C., Liu, Y.R., Chang, H.L., Chang, H.W., Huang, C.C., Wang, H.C.R., Hwang-Verslues, W.W., Wu, C.H., Ho, Y.S.*, 2019, “Long-term exposure to extremely low-dose of nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induce non-malignant breast epithelial cell transformation through activation of the a9-nicotinic acetylcholine receptor-mediated signaling pathway”, ENVIRONMENTAL TOXICOLOGY, 34(1), 73-82. (SCI)

Lee, Wen-Hwa

  • Hu CM, Tien SC, Hsieh PK, Jeng YM, Chang MC, Chang YT, Chen YJ, Chen YJ, Lee EYP, Lee WH, 2019, “High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells.”, Cell metabolism, 29(6), 1334-1349.e10. (SSCI) (IF: 20.565; SSCI ranking: 0.9%)
  • Peng HY, Chang MC, Hu CM, Yang HI, Lee WH, Chang YT, 2019, “Thrombospondin-2 is a Highly Specific Diagnostic Marker and is Associated with Prognosis in Pancreatic Cancer.”, Annals of surgical oncology, 26(3), 807-814. (SSCI) (IF: 3.857; SSCI ranking: 9%)

Lin, Kuo-I

  • Tsai, D.-Y., Hung, K.-H., Chang, C.-W., and Lin, K.-I*, 2019, “Regulatory Mechanisms of B cell responses and the implication in B cell-related diseases”, JOURNAL OF BIOMEDICAL SCIENCE, 26(1):64. (SCI)
  • Wang, Y.-H., Tsai, D.-Y., Ko, Y.-A., Yang, T.-T., Lin, I-Y., Hung, K.-H., and Lin, K.-I*, 2019, “Blimp-1 contributes to the development and function of regulatory B cells”, FRONTIERS IN IMMUNOLOGY, 10:1909. (SCI)
  • Tseng, Y,-C., Wu, C.-Y., Liu, M.-L., Chen, T.-H., Chinag, W.-L., Yu, Y.-H., Jan, J.-T., Lin, K.-I, Wong, C.-H., and Ma, C., 2019, “Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections.”, Proc Natl Acad Sci USA, 116 (10) ,4200-4205. (SCI)

Lu, Joyce Jean

  • Kuan II, Lee CC, Chen CH, Lu J, Kuo YS, Wu HC, 2019, “The extracellular domain of epithelial cell adhesion molecule (EpCAM) enhances multipotency of mesenchymal stem cells through EGFR-LIN28-LET7 signaling.”, The Journal of biological chemistry, 294(19), 7769-7786. (SSCI) (IF: 4.011; SSCI ranking: 24%)

Shen, Chia-Ning

  • Shen CN, Goh KS, Huang CR, Chiang TC, Lee CY, Jeng YM, Peng SJ, Chien HJ, Chung MH, Chou YH, Hsieh CC, Kulkarni S, Pasricha PJ, Tien YW, Tang SC, 2019, “Lymphatic vessel remodeling and invasion in pancreatic cancer progression.”, EBioMedicine, 47, 98-113. (SCI)

Yang, Hwai-I

  • Liu J, Hu HH, Chang CL, Jen CL, Lee MH, Lu SN, Wang LY, Yuan Q, Xia NS, Sugiyama M, Nishida N, Mizokami M, Chen CJ, Chen PJ, Yang HI*, 2019, “Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection.”, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 17(7):1413-1415. (SCI)
  • Wen YH, Yang HI, Chou HC, Chen CY, Hsieh WS, Tsou KI, Tsao PN, 2019, “Association of Maternal Preeclampsia with Neonatal Respiratory Distress Syndrome in Very-Low-Birth-Weight Infants.”, Scientific reports, 9(1), 13212. (SCI)
  • Huang CF, Iio E, Jun DW, Ogawa E, Toyoda H, Hsu YC, Haga H, Iwane S, Enomoto M, Lee DH, Wong G, Liu CH, Tada T, Chuang WL, Cheung R, Hayashi J, Tseng CH, Yasuda S, Tran S, Kam L, Henry L, Jeong JY, Nomura H, Park SH, Nakamuta M, Huang JF, Tai CM, Lo GH, Lee MH, Yang HI, Kao JH, Tamori A, Eguchi Y, Ueno Y, Furusyo N, Tanaka Y, Yu ML, Nguyen MH, 2019, “Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium.”, Hepatology international, 13(5), 587-598. (SCI)
  • Jeng WJ, Yang HI*, 2019, “Discrepant range of sPD-1 in different studies of chronic hepatitis B. A letter in response to Soluble programmed death-1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B.”, Journal of viral hepatitis, 26(7), 930. (SCI)
  • Yeo YH, Ho HJ, Yang HI, Tseng TC, Hosaka T, Trinh HN, Kwak MS, Park YM, Fung JYY, Buti M, Rodriguez M, Treeprasertsuk S, Preda CM, Ungtrakul T, Charatcharoenwitthaya P, Li X, Li J, Zhang J, Le MH, Wei B, Zou B, Le A, Jeong D, Chien N, Kam L, Lee CC, Riveiro-Barciela M, Istratescu D, Sriprayoon T, Chong Y, Tanwandee T, Kobayashi M, Suzuki F, Yuen MF, Lee HS, Kao JH, Lok AS, Wu CY, Nguyen MH, 2019, “Factors Associated with Rates of HBsAg Seroclearance in Adults with Chronic HBV Infection: A systematic review and meta-analysis.”, Gastroenterology, 156(3):635-646. (SCI)
  • Hu HH, Liu J, Chang CL, Jen CL, Lee MH, Lu SN, Wang LY, Quan Y, Xia NS, Chen CJ, Chen PJ*, Yang HI*, 2019, “Level of hepatitis B (HB) core antibody associates with seroclearance of HBV DNA and HB surface antigen in HB e antigen-seronegative patients.”, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 17(1):172-181. (SCI)
  • Kong Y, Jia J, Yang HI*, 2019, “Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B.”, JAMA oncology, 5(6):915-916. (SSCI) (IF: 20.871; SSCI ranking: 4.2%)
  • Lin SH, Huang YT, Yang HI, 2019, “On identification of agonistic interaction: Hepatitis B and C interaction on hepatocellular carcinoma.”, Statistics in medicine, doi: 10.1002/sim.8123. (SCI)
  • Yang HI*, Yeh ML, Wong GL, Peng CY, Chen CH, Trinh HN, Cheung KS, Xie Q, Su TH, Kozuka R, Lee DH, Ogawa E, Zhao C, Ning HB, Huang R, Li J, Zhang JQ, Ide T, Xing H, Iwane S, Takahashi H, Wong C, Wong C, Lin CH, Hoang J, le A, Henry L, Toyoda H, Ueno Y, Gane EJ, Eguchi Y, Kurosaki M, Wu C, Liu C, Shang J, Furusyo N, Enomoto M, Kao JH, Yuen MF, Yu ML, Nguyen MH*, 2019, “REAL-B (Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV) Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy.”, The Journal of infectious diseases, pii: jiz477. doi: 10.1093/infdis/jiz477. (SCI)
  • Nguyen MH, Yang HI, Le A, Henry L, Nguyen N, Lee MH, Zhang J, Wong C, Wong C, Trinh H, 2019, “Reduced Incidence of Hepatocellular Carcinoma with Tenofovir in Chronic Hepatitis B Patients with and without Cirrhosis - a Propensity Score Matched Study.”, The Journal of infectious diseases, 219(1):10-18. (SCI)
  • Chien RN, Kao JH, Peng CY, Chen CH, Liu CJ, Huang YH, Hu TH, Yang HI, Lu SN, Ni YH, Chuang WL, Lee CM, Wu JC, Chen PJ, Liaw YF, 2019, “Taiwan consensus statement on the management of chronic hepatitis B.”, JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 118(1 Pt 1):7-38.
  • Peng HY, Chang MC, Hu CM, Yang HI, Lee WH, Chang YT, 2019, “Thrombospondin-2 is a Highly Specific Diagnostic Marker and is Associated with Prognosis in Pancreatic Cancer.”, Annals of surgical oncology, 26(3):807-814. (SCI)

Language

論文集